Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 2;26(17):5325.
doi: 10.3390/molecules26175325.

Chemo-Preventive Action of Resveratrol: Suppression of p53-A Molecular Targeting Approach

Affiliations
Review

Chemo-Preventive Action of Resveratrol: Suppression of p53-A Molecular Targeting Approach

Rokeya Akter et al. Molecules. .

Abstract

Extensive experimental, clinical, and epidemiological evidence has explained and proven that products of natural origin are significantly important in preventing and/or ameliorating various disorders, including different types of cancer that researchers are extremely focused on. Among these studies on natural active substances, one can distinguish the emphasis on resveratrol and its properties, especially the potential anticancer role. Resveratrol is a natural product proven for its therapeutic activity, with remarkable anti-inflammatory properties. Various other benefits/actions have also been reported, such as cardioprotective, anti-ageing, antioxidant, etc. and its rapid digestion/absorption as well. This review aims to collect and present the latest published studies on resveratrol and its impact on cancer prevention, molecular signals (especially p53 protein participation), and its therapeutic prospects. The most recent information regarding the healing action of resveratrol is presented and concentrated to create an updated database focused on this topic presented above.

Keywords: cancer prevention; cardio protection; clinical trials; molecular signals; natural compound; p53; polyphenol; red wine; resveratrol.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow-chart describing the process of selection the references.
Figure 2
Figure 2
The contribution of p53 in the effects of resveratrol in cancer cells. MAP kinase, mitogen activated protein kinase; WTp53, wild type p53.
Figure 3
Figure 3
Potential anti-tumor effects of resveratrol. SASP, senescence-associated secretory phenotype; DLC1, deleted in liver cancer1; and ROS, reactive oxygen species.
Figure 4
Figure 4
The preventive effect of resveratrol on human health in vitro, in vivo, and clinical evidence.

References

    1. Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 2015;136:E359–E386. doi: 10.1002/ijc.29210. - DOI - PubMed
    1. Palumbo M.O., Kavan P., Miller W., Panasci L., Assouline S., Johnson N., Cohen V., Patenaude F., Pollak M., Jagoe R.T. Systemic cancer therapy: Achievements and challenges that lie ahead. Front. Pharmacol. 2013;4:57. doi: 10.3389/fphar.2013.00057. - DOI - PMC - PubMed
    1. West D.W., Slattery M.L., Robison L.M., Schuman K.L., Ford M.H., Mahoney A.W., Lyon J.L., Sorensen A.W. Dietary intake and colon cancer: Sex-and anatomic site-specific associations. Am. J. Epidemiol. 1989;130:883–894. doi: 10.1093/oxfordjournals.aje.a115421. - DOI - PubMed
    1. West D.W., Slattery M.L., Robison L.M., French T.K., Mahoney A.W. Adult dietary intake and prostate cancer risk in Utah: A case-control study with special emphasis on aggressive tumors. Cancer Causes Control. 1991;2:85–94. doi: 10.1007/BF00053126. - DOI - PubMed
    1. Howe G.R., Benito E., Castelleto R., Cornée J., Estève J., Gallagher R.P., Iscovich J.M., Deng-ao J., Kaaks R., Kune G.A. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: Evidence from the combined analysis of 13 case-control studies. JNCI J. Natl. Cancer Inst. 1992;84:1887–1896. doi: 10.1093/jnci/84.24.1887. - DOI - PubMed

MeSH terms

Substances